Dr. Horn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3601 Tvc
Nashville, TN 37232Phone+1 615-322-3000- Is this information wrong?
Education & Training
University of Toronto Faculty of MedicineClass of 2002
Certifications & Licensure
TN State Medical License 2009 - 2025
Clinical Trials
- A Randomized Phase II Study of Cisplatin and Etoposide in Combination With Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients With Extensive Stage Start of enrollment: 2009 Jul 16
- NCI 8873: Randomized Phase II Study of Single Agent OSI-906, an Oral, Small Molecule, Tyrosine Kinase Inhibitor (TKI) of the Insulin Growth Factor-1 Receptor (IGF-1R) Versus Topotecan for the Treatment of Patients With Relapsed Small Cell Lung Cancer (SCL Start of enrollment: 2011 Jun 01
- Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer Start of enrollment: 2012 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT).Laura Burns, Chih-Yuan Hsu, Jennifer G Whisenant, Melina E Marmarelis, Carolyn J Presley, Karen L Reckamp, Hina Khan, Mary Jo Fidler, Christine M Bestvina, Julie Brahm...> ;Lung Cancer. 2023 Dec 1
- Identification and Characterization of Avoidable Hospital Admissions in Patients With Lung Cancer.Eric M Lander, Xuanyi Li, Li-Ching Huang, Amanda S Cass, Wade T Iams, Emily A Skotte, Jennifer G Whisenant, Robert A Ramirez, Sally J York, Travis J Osterman, Jennifer...> ;Journal of the National Comprehensive Cancer Network. 2023 Oct 1
- Associations of influenza vaccination with severity of immune-related adverse events in patients with advanced thoracic cancers on immune checkpoint inhibitors.Emily Pei-Ying Lin, Li-Ching Huang, Jennifer Whisenant, Sally York, Travis Osterman, Jennifer Lewis, Wade Iams, Emily Skotte, Amanda Cass, Chih-Yuan Hsu, Yu Shyr, Leor...> ;ERJ Open Research. 2022 Oct 1
- Join now to see all
Journal Articles
- First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung CancerDavid S Shames, Leora Horn, Fairooz Kabbinavar, The New England Journal of Medicine
Lectures
- Sequencing theTyrosine Kinase InhibitorsASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
- eXalt3: Phase 3 randomized study comparing ensartinib to crizotinib in anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC) patients.2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
- Real-world treatment patterns and survival of BRAF V600-mutated metastatic non-small cell lung cancer patients.2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
Press Mentions
How I Decided to Hold Out for the Best Lung Cancer TreatmentDecember 9th, 2022- Black, Low-Income Patients with Cancer at Highest Risk for Severe COVID-19 ComplicationsAugust 2nd, 2021
- Kidney Damage from COVID-19 Linked to Higher Risk of in-Hospital DeathSeptember 22nd, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
